CRON Cronos Group Inc.

3.063USD4.380 CAD · TSX-1.35%Mkt Cap: 1.12B USDP/E: 19.91

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporiz…

Institutional holders20 on file

Key Statistics

Company
Market Cap1.12B USD
Enterprise Value641.84M USD
Revenue (TTM)206.20M USD
Gross Profit62.76M USD
Net Income (TTM)-9.45M USD
Revenue/Share0.55 USD
Last Price3.063 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees610
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA22717L1013
Valuation
P/E (Trailing)19.91
P/E (Forward)-73.00
PEG—
EV/EBITDA33.45
EV/Revenue3.11
P/S7.78
P/B1.07
EPS (TTM)0.22 USD
EPS (Forward)-0.06 USD
52W Range
2.25951% of range3.825
52W High3.825 USD
52W Low2.259 USD
Profitability
Gross Margin42.81%
Oper. Margin6.08%
EBITDA Margin13.31%
Profit Margin-6.44%
ROE-0.86%
ROA-0.79%
ROIC-3.12%
ROCE-1.70%
Growth
Revenue Growth74.60%
Earnings Growth-44.70%
Cash Flow & Leverage
Operating CF25.87M USD
CapEx (TTM)26.06M USD
FCF Margin9.90%
FCF Yield1.82%
Net Debt-739.96M USD
Net Debt/EBITDA-26.97
Net Debt/FCF-36.26
Balance Sheet
Debt/Equity0.00
Current Ratio12.71
Quick Ratio11.76
Book Value/Sh4.10 USD
Cash/Share2.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:7
Split DateDec 17, 2014
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.231 USD
Upside (mean)+38.1%
Target Range2.937 USD – 5.245 USD
2.937+38.1% to mean5.245
# Analysts4
Ownership
Shares Out.366.47M
Float185.02M
Insiders49.42%
Institutions16.03%
Short Interest
Short Ratio24.7d
Short % Float1.32%
Short % Out.0.65%
Shares Short2.38M
Short (prev mo.)2.52M
Technical
SMA 503.283 (-6.7%)
SMA 2002.834 (+8.1%)
Beta1.25
S&P 52W Chg8.68%
Avg Vol (30d)165.63K
Avg Vol (10d)184.45K
Technical Indicators
RSI (14)35.9
MACD-0.0390
MACD Signal0.0287
MACD Hist.-0.0677
BB Upper3.630 USD
BB Middle3.336 USD
BB Lower3.041 USD
BB Width17.64%
ATR (14)0.1170 USD
Vol Ratio (20d)1.30x

About Cronos Group (TSE: CRON)

›

Cronos Group (TSE: CRON) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 610 employees.

The shares were at 4.380 CAD on 20 November 2026, up 26.2% over 52 weeks. Its 52-week range is 3.230 CAD to 5.470 CAD: the price is 19.9% below the high and 35.6% above the low.

At a market capitalisation of 1.61B CAD, it trades at 19.9 times trailing earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.5, a discount of 19% for CRON.

Cronos Group reports return on equity of -0.9%, an operating margin of 6.1% and revenue up 74.6% year over year.

It holds more cash than debt, a net cash position of 739.96M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 6.050 CAD is 38.1% above the current price. The next earnings report is expected on 25 February 2027.